企業プロフィール · Financial Services

MetLife Inc

MET · 米国株
業種
Insurance
取引所
米国株
国 / 地域
USA
上場日
2000年4月5日
従業員数
46,000
公式サイト
www.metlife.com
現在値
$85.58
リアルタイム · 2026年6月18日
妥当買付価格
≤ $78
安全マージンの起点
ベイリー成長スコア
40/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $85.58 リアルタイム · 妥当な本源的価値レンジ内

総合バリュエーションレンジ · 保守的 $70–$85 / 妥当 $85–$100 / 楽観的 $100–$115。$85.58 時点で 妥当な本源的価値レンジ内。

レポート公開時 $83.27(2026年5月27日)

この銘柄のレポートはお使いの言語でまだありません。

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

時価総額$552.39億
売上高(TTM)$775.84億
EBITDA$59.43億
純利益率4.67%
ROE13.01%
PER (TTM)16.61
予想PER9.43
PEG0.45
EPS$5.17
配当利回り2.6%
52週レンジ$66.82 – $89.62
アナリスト目標株価$92.00
アナリスト評価4.2 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。